Jane Street
ALZN icon

Jane Street’s Alzamend Neuro ALZN Stock Holding History

Jane Street’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9
Closed -$5.1K – 8610
2023
Q1 		$5.1K Sell
9
-1
-10% -$752 ﹤0.01% 8808
2022
Q4 		$7.71K Buy
+10
New +$14.5K ﹤0.01% 8803
2022
Q2 		– Sell
-12
Closed -$20K – 9571
2022
Q1 		$20K Sell
12
-17
-59% -$31.9K ﹤0.01% 9936
2021
Q4 		$75K Sell
29
-11
-28% -$34K ﹤0.01% 9369
2021
Q3 		$168K Sell
40
-59
-60% -$324K ﹤0.01% 8975
2021
Q2 		$1.17M Buy
+99
New +$1.28M ﹤0.01% 5498

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IIC
Integrated Investment Consultants Bloomfield Hills, Michigan $471M AUM 20.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's ALZN Position: Q2 2023 in Review

Jane Street sold out of Alzamend Neuro (ALZN) in Q2 2023, closing a stake of 9 shares — an estimated $5.1K sold.

Jane Street first reported a position in ALZN in Q2 2021 and held it in 6 quarters. The position peaked at $1.17M in Q2 2021. 20 funds tracked by Wall St. Rank hold ALZN as of Q2 2023.

  • Jane Street reported no remaining Alzamend Neuro position as of Q2 2023 after selling out during the quarter.
  • Jane Street sold 9 Alzamend Neuro shares in Q2 2023, an estimated $5.1K.
  • Jane Street first reported a position in Alzamend Neuro in Q2 2021 and held it in 6 quarters.
  • Jane Street's Alzamend Neuro position peaked at $1.17M in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Alzamend Neuro as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.